Stopped: A national Covid-19 lockdown prevented completion of the trial
This study's primary objective is to perform a randomized controlled pilot study to assess the feasibility of using EEG-based neurofeedback to reduce the severity of treatment-resistant auditory verbal hallucinations ('hearing voices') in patients diagnosed with schizophrenia. Patients will be randomized to receive either EEG-based neurofeedback or treatment-as-usual.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Recruitment rate
Timeframe: 24 months
Willingness of participants to be randomised.
Timeframe: 24 months
Willingness of participants to complete assessments
Timeframe: 24 months
Drop-out rate: LORETA condition
Timeframe: 24 months
Success of blinding of raters
Timeframe: 24 months
Rates of adverse psychiatric events
Timeframe: 24 months
Drop-out rate: Controls
Timeframe: 24 months